CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing government and NGO initiatives to encourage organ donation
4.1.2. Rising cases of multiple organ failure in the aging population coupled with technological
advancements in organ preservation
4.1.3. Rising number of solid-organ transplantation procedures
4.1.4. Normothermic machine perfusion is a new paradigm for organ preservation
4.2. Market Restraints & Challenges
4.2.1. The significant gap between the number of organs donated and organs required
annually
4.2.2. Limited medical reimbursements for organ donation and transplantation
4.2.3. The high cost of organ transplantation
CHAPTER 5 GLOBAL ORGAN PRESERVATION MARKET – BY SOLUTION TYPE
5.1. Perfadex
5.2. University of Wisconsin Solution
5.3. Custodiol HTK
5.4. Others
CHAPTER 6 GLOBAL ORGAN PRESERVATION MARKET – BY TECHNIQUE
6.1. Hypothermic Machine Perfusion
6.2. Normothermic Machine Perfusion
6.3. Static Cold Storage Technique
CHAPTER 7 GLOBAL ORGAN PRESERVATION MARKET – BY ORGAN TYPE
7.1. Lung
7.2. Liver
7.3. Heart
7.4. Kidneys
7.5. Others
CHAPTER 8 GLOBAL ORGAN PRESERVATION MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL ORGAN PRESERVATION MARKET - COMPANY PROFILES
9.1. Organ Recovery Systems, Inc.
9.2. Preservation Solutions, Inc.
9.3. XVIVO Perfusion AB
9.4. TransMedics, Inc.
9.5. OrganOx, Ltd.
9.6. Bridge to Life, Ltd.
9.7. Waters Medical Systems, LLC
9.8. Essential Pharmaceuticals, LLC
9.9. Dr. Franz Köhler Chemie GmbH
9.10. 21st Century Medicine Inc.
9.11. Paragonix Technologies, Inc.
CHAPTER 10 GLOBAL ORGAN PRESERVATION MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
